Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 6
2012 5
2013 5
2014 8
2015 3
2016 1
2017 3
2018 1
2019 1
2020 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean Ezziddin and (skirt or radioembolisation) (27 results)?
Radioembolization of liver tumors with yttrium-90 microspheres.
Ahmadzadehfar H, Biersack HJ, Ezziddin S. Ahmadzadehfar H, et al. Semin Nucl Med. 2010 Mar;40(2):105-21. doi: 10.1053/j.semnuclmed.2009.11.001. Semin Nucl Med. 2010. PMID: 20113679 Review.
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. ...However, the interdisciplinary aspect of patient management has to be emphasized fo …
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been gradually introduced to the clinical …
90Y Radioembolization after radiation exposure from peptide receptor radionuclide therapy.
Ezziddin S, Meyer C, Kahancova S, Haslerud T, Willinek W, Wilhelm K, Biersack HJ, Ahmadzadehfar H. Ezziddin S, et al. J Nucl Med. 2012 Nov;53(11):1663-9. doi: 10.2967/jnumed.112.107482. Epub 2012 Sep 17. J Nucl Med. 2012. PMID: 22988059 Free article.
Previous radiation therapy of the liver is a contraindication for performing (90)Y microsphere radioembolization, and its safety after internal radiation exposure through peptide receptor radionuclide therapy (PRRT) has not yet been investigated. ...The median overall surv …
Previous radiation therapy of the liver is a contraindication for performing (90)Y microsphere radioembolization, and its safety afte …
Radioembolisation in patients with hepatocellular carcinoma that have previously received liver-directed therapies.
Sangro B, Maini CL, Ettorre GM, Cianni R, Golfieri R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Van Buskirk M, Bilbao JI, Salvatori R, Giampalma E, Geatti O, Wilhelm K, Hoffmann RT, Izzo F, Iñarrairaegui M, Urigo C, Cappelli A, Vit A, Ahmadzadehfar H, Jakobs TF, Sciuto R, Pizzi G, Lastoria S; European Network on Radioembolization with Yttrium-90 resin microspheres (ENRY). Sangro B, et al. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1721-1730. doi: 10.1007/s00259-018-3968-5. Epub 2018 Mar 7. Eur J Nucl Med Mol Imaging. 2018. PMID: 29516130 Free PMC article.
PURPOSE: Radioembolisation is part of the multimodal treatment of hepatocellular carcinoma (HCC) at specialist liver centres. ...Radioembolisation was used first-line in 57.5% of patients and second-line in 34.2%. ...
PURPOSE: Radioembolisation is part of the multimodal treatment of hepatocellular carcinoma (HCC) at specialist liver centres. ...R …
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
Golfieri R, Bilbao JI, Carpanese L, Cianni R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Cappelli A, Rodriguez M, Ettorre GM, Saltarelli A, Geatti O, Ahmadzadehfar H, Haug AR, Izzo F, Giampalma E, Sangro B, Pizzi G, Notarianni E, Vit A, Wilhelm K, Jakobs TF, Lastoria S; European Network on Radioembolization with Yttrium-90 Microspheres (ENRY) study collaborators. Golfieri R, et al. J Hepatol. 2013 Oct;59(4):753-61. doi: 10.1016/j.jhep.2013.05.025. Epub 2013 May 23. J Hepatol. 2013. PMID: 23707371 Clinical Trial.
BACKGROUND & AIMS: The European Network on Radioembolization with Yttrium-90 resin microspheres study group (ENRY) conducted a retrospective study to evaluate the outcomes among elderly ( 70 years) and younger patients (<70 years) with unresectable hepatocellular ca …
BACKGROUND & AIMS: The European Network on Radioembolization with Yttrium-90 resin microspheres study group (ENRY) conducted a re …
Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).
Helmberger T, Golfieri R, Pech M, Pfammatter T, Arnold D, Cianni R, Maleux G, Munneke G, Pellerin O, Peynircioglu B, Sangro B, Schaefer N, de Jong N, Bilbao JI; On behalf of the CIRT Steering Committee; On behalf of the CIRT Principal Investigators. Helmberger T, et al. Cardiovasc Intervent Radiol. 2021 Jan;44(1):21-35. doi: 10.1007/s00270-020-02642-y. Epub 2020 Sep 21. Cardiovasc Intervent Radiol. 2021. PMID: 32959085 Free PMC article.
PURPOSE: To address the lack of prospective data on the real-life clinical application of trans-arterial radioembolization (TARE) in Europe, the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) initiated the prospective observational study CIRSE Reg …
PURPOSE: To address the lack of prospective data on the real-life clinical application of trans-arterial radioembolization (TARE) in …
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization.
Bellendorf A, Mader N, Mueller SP, Ezziddin S, Bockisch A, Grafe H, Best J, Goebel J, Pöppel TD, Sabet A. Bellendorf A, et al. Pharmaceuticals (Basel). 2024 Jan 11;17(1):101. doi: 10.3390/ph17010101. Pharmaceuticals (Basel). 2024. PMID: 38256934 Free PMC article.
Treatment response was assessed three months after SIRT using multiphase computed tomography and modified criteria in solid tumors (mRECIST). ...Significant but reversible hepatotoxicity (grade 3) occurred in five patients (11%). No radioembolization-induced liver d …
Treatment response was assessed three months after SIRT using multiphase computed tomography and modified criteria in solid tumors (m …
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, Paprottka PM, Fiore F, Van Buskirk M, Bilbao JI, Ettorre GM, Salvatori R, Giampalma E, Geatti O, Wilhelm K, Hoffmann RT, Izzo F, Iñarrairaegui M, Maini CL, Urigo C, Cappelli A, Vit A, Ahmadzadehfar H, Jakobs TF, Lastoria S; European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY). Sangro B, et al. Hepatology. 2011 Sep 2;54(3):868-78. doi: 10.1002/hep.24451. Epub 2011 Jun 30. Hepatology. 2011. PMID: 21618574
A multicenter analysis was conducted to evaluate the main prognostic factors driving survival after radioembolization using yttrium-90-labeled resin microspheres in patients with hepatocellular carcinoma at eight European centers. ...CONCLUSION: This analysis provides robu …
A multicenter analysis was conducted to evaluate the main prognostic factors driving survival after radioembolization using yttrium-9 …
The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.
Ahmadzadehfar H, Sabet A, Biermann K, Muckle M, Brockmann H, Kuhl C, Wilhelm K, Biersack HJ, Ezziddin S. Ahmadzadehfar H, et al. J Nucl Med. 2010 Aug;51(8):1206-12. doi: 10.2967/jnumed.109.074559. Epub 2010 Jul 21. J Nucl Med. 2010. PMID: 20660379 Free article.
Our aim was to compare the ability of SPECT/CT with that of planar imaging and SPECT in the detection and localization of extrahepatic (99m)Tc-MAA accumulation and to evaluate the impact of SPECT/CT on SIRT treatment planning and its added value to angiography in this sett …
Our aim was to compare the ability of SPECT/CT with that of planar imaging and SPECT in the detection and localization of extrahepatic (99m) …
Feasibility of temporary protective embolization of normal liver tissue using degradable starch microspheres during radioembolization of liver tumours.
Meyer C, Pieper CC, Ezziddin S, Wilhelm KE, Schild HH, Ahmadzadehfar H. Meyer C, et al. Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):231-7. doi: 10.1007/s00259-013-2550-4. Epub 2013 Sep 13. Eur J Nucl Med Mol Imaging. 2014. PMID: 24030669 Clinical Trial.
PURPOSE: To describe a new approach to protect nontarget healthy liver tissue using degradable starch microspheres (DSM) as a short-term embolizate during radioembolization of liver tumours with (90)Y microspheres. METHODS: Between December 2011 and July 2012 radioembol …
PURPOSE: To describe a new approach to protect nontarget healthy liver tissue using degradable starch microspheres (DSM) as a short-term emb …
Radioembolization as a Treatment Option.
Ezziddin S, Bücker A, Lammert F. Ezziddin S, et al. Dtsch Arztebl Int. 2015 May 25;112(21-22):372-3. doi: 10.3238/arztebl.2015.0372b. Dtsch Arztebl Int. 2015. PMID: 26149377 Free PMC article. No abstract available.
30 results